查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1423838

全球宿主细胞污染物测试市场 - 全球产业分析、规模、份额、成长、趋势、预测 (2031) - 按产品类型、按平台、按应用、按最终用户、按地区

Host Cell Contaminant Testing Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region:
出版日期: | 出版商: Fairfield Market Research | 英文 198 Pages | 商品交期: 2-5个工作天内

价格
简介目录

在生物製药的动态模式中，宿主细胞污染物的识别和定量是确保新型疗法的安全性和有效性的关键挑战。 来自各种来源（包括酵母菌、大肠桿菌和哺乳动物细胞）的宿主细胞蛋白是具有不同特性、等电点和分子量的异质混合物。 随着生物製药产业不断创新，对强大的宿主细胞污染物测试解决方案的需求不断增加。

在宿主细胞污染物检测领域的不同利益相关者中，生物製药公司已成为领跑者，以其巨大的市场份额和在药物开发和製造方面的丰富专业知识推动市场发展。Masu。 根据最近的市场分析，生物製药公司在全球宿主细胞污染物检测市场中占有重要份额，预计这一趋势在预测期内将持续下去。

拥有成熟生产能力、经济实力和战略市场基础设施□□的大型生物製药公司在新药研发和市场开拓中发挥着至关重要的作用。 此外，这些公司经常与新兴生物製药公司合作，利用它们的资源筹集研究资金，扩大客户群，并应对药物开发和商业化的复杂局面。我正在克服它。

生物製药公司认识到宿主细胞污染物测试对于确保产品品质和法规遵循至关重要，因此越来越多地投资于先进的测试方法。 这些公司旨在透过优先考虑抗体和小分子药物等风险较低的后期产品来降低风险，同时加快药物开发和商业化的步伐。

随着生物製药公司的崛起，合约研究组织 (CRO) 有望成为宿主细胞污染物检测市场的强大竞争对手。 透过与领先製药公司的策略联盟和协议，CRO 利用其临床前和临床研究专业知识提供全面的检测服务。

与稀释现有投资者股权的传统投资模式不同，CRO 正在探索替代融资途径，并将自己定位为药物开发生态系统中的重要合作伙伴。 透过进行临床前评估、毒性测试和临床试验，CRO 在加速药物开发过程、同时确保法规遵循和患者安全方面发挥关键作用。

同样，合约製造组织 (CMO) 是生物製药价值链不可或缺的一部分，提供针对特定製药要求的专业製造能力。 透过与 CRO 和生物製药公司密切合作，CMO 促进从药物开发到商业生产的无缝过渡，确保整个产品生命週期的可扩展性和效率。

由于对新治疗剂的不断追求以及对品质保证和监管合规性的日益重视，全球宿主细胞污染物检测市场预计未来将显着扩大。 随着生物製药公司继续推动创新并建立策略合作伙伴关係，对先进测试解决方案的需求预计将激增。

本报告调查了全球宿主细胞污染物测试市场，并提供了市场概述，以及按产品类型、平台、应用、最终用户、区域和进入市场的竞争对手划分的趋势。我们提供了趋势等。

目录

第 1 章执行摘要

第二章市场概述

  • 市场定义与细分
  • 市场动态
  • 价值链分析
  • 波特五力分析
  • 新冠肺炎 (COVID-19) 影响分析
  • 乌克兰和俄罗斯之间衝突的影响
  • 经济概况
  • 杵分析

第 3 章 2018-2031 年全球宿主细胞污染物检测市场前景

  • 2018-2031 年全球宿主细胞污染物测试市场前景（按产品类型、价值（十亿美元））
  • 2018-2031 年全球宿主细胞污染物测试市场前景（按平台划分）、价值（十亿美元）
  • 2018-2031 年全球宿主细胞污染物测试市场前景（按应用、价值（十亿美元））
  • 2018-2031 年全球宿主细胞污染物测试市场前景（按最终用户划分）价值（十亿美元）
  • 2018-2031 年全球宿主细胞污染物测试市场前景（按地区、价值（十亿美元））

第 4 章北美宿主细胞污染物测试市场前景，2018-2031

第 5 章欧洲宿主细胞污染物测试市场前景，2018-2031

第 6 章亚太地区宿主细胞污染物测试市场展望，2018-2031 年

第 7 章拉丁美洲宿主细胞污染物测试市场展望，2018-2031 年

第 8 章中东与非洲宿主细胞污染物检测市场前景，2018-2031 年

第九章竞争态势

  • 产品类型与平台热图
  • 製造商和平台热图
  • 2023 年公司市占率分析
  • 竞争力仪表板
  • 公司简介
    • BioGenes GmbH
    • Bio-Rad Laboratories, Inc.
    • Cisbio Bioassays
    • Cygnus Technologies LLC
    • Enzo Life Sciences, Inc.
    • ForteBio
    • GE Healthcare Life Sciences
    • Molecular Devices LLC
    • ProteinSimple
    • Thermo Fisher Scientific, Inc.

第 10 章附录

简介目录

In the dynamic landscape of biopharmaceuticals, the identification and quantification of host cell contaminants stand as pivotal tasks in ensuring the safety and efficacy of novel therapeutics. Host cell proteins, originating from diverse sources such as yeast, E. coli, and mammalian cells, present a heterogeneous mix with varying properties, isoelectric points, and molecular masses. As the biopharmaceutical industry continues to innovate, the demand for robust host cell contaminant testing solutions is on the rise.

Bio-Pharmaceutical Companies Spearhead Market Growth

Among the diverse stakeholders in the host cell contaminant testing arena, bio-pharmaceutical companies emerge as frontrunners, driving market expansion with their substantial market share and extensive expertise in drug development and manufacturing. Recent market analysis indicates that bio-pharmaceutical companies commanded a significant share in the global host cell contaminant testing market, a trend projected to persist in the forecast period.

With their established production capabilities, economic prowess, and strategic market infrastructure, bio-pharmaceutical giants play a pivotal role in shepherding novel drugs from development to market introduction. Moreover, these companies often engage in partnerships and collaborations with emerging biopharmaceutical entities, leveraging their resources to finance research, expand customer bases, and navigate the complex landscape of drug development and commercialization.

Recognizing the critical importance of host cell contaminant testing in ensuring product quality and regulatory compliance, bio-pharmaceutical companies are increasingly investing in advanced testing methodologies. By prioritizing low-risk, late-stage products such as antibodies and small molecule drugs, these companies aim to mitigate risks while accelerating the pace of drug development and commercialization.

Rising Role of Contract Research Organizations (CROs)

In tandem with the ascendancy of bio-pharmaceutical companies, contract research organizations (CROs) are poised to emerge as formidable contenders in the host cell contaminant testing market. Through strategic partnerships and agreements with leading pharmaceutical entities, CROs are leveraging their expertise in preclinical and clinical research to offer comprehensive testing services.

Unlike traditional investment models that dilute existing investor stakes, CROs are exploring alternative financing avenues, positioning themselves as indispensable partners in the drug development ecosystem. By conducting preclinical evaluations, toxicology studies, and clinical trials, CROs play a vital role in expediting the drug development process while ensuring regulatory compliance and patient safety.

Similarly, contract manufacturing organizations (CMOs) are integral players in the biopharmaceutical value chain, offering specialized manufacturing capabilities tailored to specific drug requirements. By collaborating closely with CROs and bio-pharmaceutical companies, CMOs facilitate seamless transitions from drug development to commercial production, ensuring scalability and efficiency throughout the product lifecycle.

Market Outlook and Future Prospects

Looking ahead, the global host cell contaminant testing market is poised for significant expansion, driven by the relentless pursuit of novel therapeutics and the increasing emphasis on quality assurance and regulatory compliance. As bio-pharmaceutical companies continue to drive innovation and forge strategic partnerships, the demand for advanced testing solutions is expected to surge.

Moreover, the growing role of CROs and CMOs in the biopharmaceutical ecosystem underscores the importance of collaborative approaches in drug development and manufacturing. By harnessing collective expertise and resources, stakeholders across the industry are poised to accelerate the pace of innovation and bring life-saving treatments to patients worldwide.

Competitive Analysis

Key companies functioning in the global host cell contaminant testing market including:

  • BioGenes GmbH
  • Bio-Rad Laboratories, Inc.
  • Cisbio Bioassays
  • Cygnus Technologies LLC (A Maravai Lifesciences Company)
  • Enzo Life Sciences, Inc.
  • ForteBio (A Pall Company)
  • GE Healthcare Life Sciences
  • Molecular Devices LLC
  • ProteinSimple (A BioTechne Brand)
  • Thermo Fisher Scientific, Inc.
  • Others

Market Segmentation

Product Type

  • PCR-based Assays
  • ELISA-based Assays

Platform

  • Microbial
  • Mammalian
  • Others

Application

  • Research & Development
  • Clinical Applications

End User

  • Biopharmaceutical Companies
  • Contract Research Organizations
  • Contract Manufacturing Organizations
  • Academic & Research Institutes

Region

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Host Cell Contaminant Testing Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value, 2023
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. Porter's Five Forces Analysis
  • 2.5. COVID-19 Impact Analysis
    • 2.5.1. Supply
    • 2.5.2. Demand
  • 2.6. Impact of Ukraine-Russia Conflict
  • 2.7. Economic Overview
    • 2.7.1. World Economic Projections
  • 2.8. PESTLE Analysis

3. Global Host Cell Contaminant Testing Market Outlook, 2018 - 2031

  • 3.1. Global Host Cell Contaminant Testing Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
    • 3.1.1. Key Highlights
      • 3.1.1.1. PCR-based Assays
      • 3.1.1.2. ELISA-based Assays
  • 3.2. Global Host Cell Contaminant Testing Market Outlook, by Platform, Value (US$ Bn), 2018 - 2031
    • 3.2.1. Key Highlights
      • 3.2.1.1. Microbial
      • 3.2.1.2. Mammalian
      • 3.2.1.3. Others
  • 3.3. Global Host Cell Contaminant Testing Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
    • 3.3.1. Key Highlights
      • 3.3.1.1. Research & Development
      • 3.3.1.2. Clinical Applications
  • 3.4. Global Host Cell Contaminant Testing Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
    • 3.4.1. Key Highlights
      • 3.4.1.1. Biopharmaceutical Companies
      • 3.4.1.2. Contract Research Organizations
      • 3.4.1.3. Contract Manufacturing Organizations
      • 3.4.1.4. Academic & Research Institutes
  • 3.5. Global Host Cell Contaminant Testing Market Outlook, by Region, Value (US$ Bn), 2018 - 2031
    • 3.5.1. Key Highlights
      • 3.5.1.1. North America
      • 3.5.1.2. Europe
      • 3.5.1.3. Asia Pacific
      • 3.5.1.4. Latin America
      • 3.5.1.5. Middle East & Africa

4. North America Host Cell Contaminant Testing Market Outlook, 2018 - 2031

  • 4.1. North America Host Cell Contaminant Testing Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
    • 4.1.1. Key Highlights
      • 4.1.1.1. PCR-based Assays
      • 4.1.1.2. ELISA-based Assays
  • 4.2. North America Host Cell Contaminant Testing Market Outlook, by Platform, Value (US$ Bn), 2018 - 2031
    • 4.2.1. Key Highlights
      • 4.2.1.1. Microbial
      • 4.2.1.2. Mammalian
      • 4.2.1.3. Others
  • 4.3. North America Host Cell Contaminant Testing Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
    • 4.3.1. Key Highlights
      • 4.3.1.1. Research & Development
      • 4.3.1.2. Clinical Applications
  • 4.4. North America Host Cell Contaminant Testing Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
    • 4.4.1. Key Highlights
      • 4.4.1.1. Biopharmaceutical Companies
      • 4.4.1.2. Contract Research Organizations
      • 4.4.1.3. Contract Manufacturing Organizations
      • 4.4.1.4. Academic & Research Institutes
  • 4.5. North America Host Cell Contaminant Testing Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 4.5.1. Key Highlights
      • 4.5.1.1. U.S. Host Cell Contaminant Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 4.5.1.2. U.S. Host Cell Contaminant Testing Market by Platform, Value (US$ Bn), 2018 - 2031
      • 4.5.1.3. U.S. Host Cell Contaminant Testing Market by Application, Value (US$ Bn), 2018 - 2031
      • 4.5.1.4. U.S. Host Cell Contaminant Testing Market by End User, Value (US$ Bn), 2018 - 2031
      • 4.5.1.5. Canada Host Cell Contaminant Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 4.5.1.6. Canada Host Cell Contaminant Testing Market by Platform, Value (US$ Bn), 2018 - 2031
      • 4.5.1.7. Canada Host Cell Contaminant Testing Market by Application, Value (US$ Bn), 2018 - 2031
      • 4.5.1.8. Canada Host Cell Contaminant Testing Market by End User, Value (US$ Bn), 2018 - 2031
    • 4.5.2. BPS Analysis/Market Attractiveness Analysis

5. Europe Host Cell Contaminant Testing Market Outlook, 2018 - 2031

  • 5.1. Europe Host Cell Contaminant Testing Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
    • 5.1.1. Key Highlights
      • 5.1.1.1. PCR-based Assays
      • 5.1.1.2. ELISA-based Assays
  • 5.2. Europe Host Cell Contaminant Testing Market Outlook, by Platform, Value (US$ Bn), 2018 - 2031
    • 5.2.1. Key Highlights
      • 5.2.1.1. Microbial
      • 5.2.1.2. Mammalian
      • 5.2.1.3. Others
  • 5.3. Europe Host Cell Contaminant Testing Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
    • 5.3.1. Key Highlights
      • 5.3.1.1. Research & Development
      • 5.3.1.2. Clinical Applications
  • 5.4. Europe Host Cell Contaminant Testing Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
    • 5.4.1. Key Highlights
      • 5.4.1.1. Biopharmaceutical Companies
      • 5.4.1.2. Contract Research Organizations
      • 5.4.1.3. Contract Manufacturing Organizations
      • 5.4.1.4. Academic & Research Institutes
  • 5.5. Europe Host Cell Contaminant Testing Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 5.5.1. Key Highlights
      • 5.5.1.1. Germany Host Cell Contaminant Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 5.5.1.2. Germany Host Cell Contaminant Testing Market by Platform, Value (US$ Bn), 2018 - 2031
      • 5.5.1.3. Germany Host Cell Contaminant Testing Market by Application, Value (US$ Bn), 2018 - 2031
      • 5.5.1.4. Germany Host Cell Contaminant Testing Market by End User, Value (US$ Bn), 2018 - 2031
      • 5.5.1.5. U.K. Host Cell Contaminant Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 5.5.1.6. U.K. Host Cell Contaminant Testing Market by Platform, Value (US$ Bn), 2018 - 2031
      • 5.5.1.7. U.K. Host Cell Contaminant Testing Market by Application, Value (US$ Bn), 2018 - 2031
      • 5.5.1.8. U.K. Host Cell Contaminant Testing Market by End User, Value (US$ Bn), 2018 - 2031
      • 5.5.1.9. France Host Cell Contaminant Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 5.5.1.10. France Host Cell Contaminant Testing Market by Platform, Value (US$ Bn), 2018 - 2031
      • 5.5.1.11. France Host Cell Contaminant Testing Market by Application, Value (US$ Bn), 2018 - 2031
      • 5.5.1.12. France Host Cell Contaminant Testing Market by End User, Value (US$ Bn), 2018 - 2031
      • 5.5.1.13. Italy Host Cell Contaminant Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 5.5.1.14. Italy Host Cell Contaminant Testing Market by Platform, Value (US$ Bn), 2018 - 2031
      • 5.5.1.15. Italy Host Cell Contaminant Testing Market by Application, Value (US$ Bn), 2018 - 2031
      • 5.5.1.16. Italy Host Cell Contaminant Testing Market by End User, Value (US$ Bn), 2018 - 2031
      • 5.5.1.17. Turkey Host Cell Contaminant Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 5.5.1.18. Turkey Host Cell Contaminant Testing Market by Platform, Value (US$ Bn), 2018 - 2031
      • 5.5.1.19. Turkey Host Cell Contaminant Testing Market by Application, Value (US$ Bn), 2018 - 2031
      • 5.5.1.20. Turkey Host Cell Contaminant Testing Market by End User, Value (US$ Bn), 2018 - 2031
      • 5.5.1.21. Russia Host Cell Contaminant Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 5.5.1.22. Russia Host Cell Contaminant Testing Market by Platform, Value (US$ Bn), 2018 - 2031
      • 5.5.1.23. Russia Host Cell Contaminant Testing Market by Application, Value (US$ Bn), 2018 - 2031
      • 5.5.1.24. Russia Host Cell Contaminant Testing Market by End User, Value (US$ Bn), 2018 - 2031
      • 5.5.1.25. Rest of Europe Host Cell Contaminant Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 5.5.1.26. Rest of Europe Host Cell Contaminant Testing Market by Platform, Value (US$ Bn), 2018 - 2031
      • 5.5.1.27. Rest of Europe Host Cell Contaminant Testing Market by Application, Value (US$ Bn), 2018 - 2031
      • 5.5.1.28. Rest of Europe Host Cell Contaminant Testing Market by End User, Value (US$ Bn), 2018 - 2031
    • 5.5.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Host Cell Contaminant Testing Market Outlook, 2018 - 2031

  • 6.1. Asia Pacific Host Cell Contaminant Testing Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
    • 6.1.1. Key Highlights
      • 6.1.1.1. PCR-based Assays
      • 6.1.1.2. ELISA-based Assays
  • 6.2. Asia Pacific Host Cell Contaminant Testing Market Outlook, by Platform, Value (US$ Bn), 2018 - 2031
    • 6.2.1. Key Highlights
      • 6.2.1.1. Microbial
      • 6.2.1.2. Mammalian
      • 6.2.1.3. Others
  • 6.3. Asia Pacific Host Cell Contaminant Testing Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
    • 6.3.1. Key Highlights
      • 6.3.1.1. Research & Development
      • 6.3.1.2. Clinical Applications
  • 6.4. Asia Pacific Host Cell Contaminant Testing Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
    • 6.4.1. Key Highlights
      • 6.4.1.1. Biopharmaceutical Companies
      • 6.4.1.2. Contract Research Organizations
      • 6.4.1.3. Contract Manufacturing Organizations
      • 6.4.1.4. Academic & Research Institutes
  • 6.5. Asia Pacific Host Cell Contaminant Testing Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 6.5.1. Key Highlights
      • 6.5.1.1. China Host Cell Contaminant Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 6.5.1.2. China Host Cell Contaminant Testing Market by Platform, Value (US$ Bn), 2018 - 2031
      • 6.5.1.3. China Host Cell Contaminant Testing Market by Application, Value (US$ Bn), 2018 - 2031
      • 6.5.1.4. China Host Cell Contaminant Testing Market by End User, Value (US$ Bn), 2018 - 2031
      • 6.5.1.5. Japan Host Cell Contaminant Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 6.5.1.6. Japan Host Cell Contaminant Testing Market by Platform, Value (US$ Bn), 2018 - 2031
      • 6.5.1.7. Japan Host Cell Contaminant Testing Market by Application, Value (US$ Bn), 2018 - 2031
      • 6.5.1.8. Japan Host Cell Contaminant Testing Market by End User, Value (US$ Bn), 2018 - 2031
      • 6.5.1.9. South Korea Host Cell Contaminant Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 6.5.1.10. South Korea Host Cell Contaminant Testing Market by Platform, Value (US$ Bn), 2018 - 2031
      • 6.5.1.11. South Korea Host Cell Contaminant Testing Market by Application, Value (US$ Bn), 2018 - 2031
      • 6.5.1.12. South Korea Host Cell Contaminant Testing Market by End User, Value (US$ Bn), 2018 - 2031
      • 6.5.1.13. India Host Cell Contaminant Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 6.5.1.14. India Host Cell Contaminant Testing Market by Platform, Value (US$ Bn), 2018 - 2031
      • 6.5.1.15. India Host Cell Contaminant Testing Market by Application, Value (US$ Bn), 2018 - 2031
      • 6.5.1.16. India Host Cell Contaminant Testing Market by End User, Value (US$ Bn), 2018 - 2031
      • 6.5.1.17. Southeast Asia Host Cell Contaminant Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 6.5.1.18. Southeast Asia Host Cell Contaminant Testing Market by Platform, Value (US$ Bn), 2018 - 2031
      • 6.5.1.19. Southeast Asia Host Cell Contaminant Testing Market by Application, Value (US$ Bn), 2018 - 2031
      • 6.5.1.20. Southeast Asia Host Cell Contaminant Testing Market by End User, Value (US$ Bn), 2018 - 2031
      • 6.5.1.21. Rest of Asia Pacific Host Cell Contaminant Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 6.5.1.22. Rest of Asia Pacific Host Cell Contaminant Testing Market by Platform, Value (US$ Bn), 2018 - 2031
      • 6.5.1.23. Rest of Asia Pacific Host Cell Contaminant Testing Market by Application, Value (US$ Bn), 2018 - 2031
      • 6.5.1.24. Rest of Asia Pacific Host Cell Contaminant Testing Market by End User, Value (US$ Bn), 2018 - 2031
    • 6.5.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America Host Cell Contaminant Testing Market Outlook, 2018 - 2031

  • 7.1. Latin America Host Cell Contaminant Testing Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
    • 7.1.1. Key Highlights
      • 7.1.1.1. PCR-based Assays
      • 7.1.1.2. ELISA-based Assays
  • 7.2. Latin America Host Cell Contaminant Testing Market Outlook, by Platform, Value (US$ Bn), 2018 - 2031
    • 7.2.1. Key Highlights
      • 7.2.1.1. Microbial
      • 7.2.1.2. Mammalian
      • 7.2.1.3. Others
  • 7.3. Latin America Host Cell Contaminant Testing Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
    • 7.3.1. Key Highlights
      • 7.3.1.1. Research & Development
      • 7.3.1.2. Clinical Applications
  • 7.4. Latin America Host Cell Contaminant Testing Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
    • 7.4.1. Key Highlights
      • 7.4.1.1. Biopharmaceutical Companies
      • 7.4.1.2. Contract Research Organizations
      • 7.4.1.3. Contract Manufacturing Organizations
      • 7.4.1.4. Academic & Research Institutes
  • 7.5. Latin America Host Cell Contaminant Testing Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 7.5.1. Key Highlights
      • 7.5.1.1. Brazil Host Cell Contaminant Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 7.5.1.2. Brazil Host Cell Contaminant Testing Market by Platform, Value (US$ Bn), 2018 - 2031
      • 7.5.1.3. Brazil Host Cell Contaminant Testing Market by Application, Value (US$ Bn), 2018 - 2031
      • 7.5.1.4. Brazil Host Cell Contaminant Testing Market by End User, Value (US$ Bn), 2018 - 2031
      • 7.5.1.5. Mexico Host Cell Contaminant Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 7.5.1.6. Mexico Host Cell Contaminant Testing Market by Platform, Value (US$ Bn), 2018 - 2031
      • 7.5.1.7. Mexico Host Cell Contaminant Testing Market by Application, Value (US$ Bn), 2018 - 2031
      • 7.5.1.8. Mexico Host Cell Contaminant Testing Market by End User, Value (US$ Bn), 2018 - 2031
      • 7.5.1.9. Argentina Host Cell Contaminant Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 7.5.1.10. Argentina Host Cell Contaminant Testing Market by Platform, Value (US$ Bn), 2018 - 2031
      • 7.5.1.11. Argentina Host Cell Contaminant Testing Market by Application, Value (US$ Bn), 2018 - 2031
      • 7.5.1.12. Argentina Host Cell Contaminant Testing Market by End User, Value (US$ Bn), 2018 - 2031
      • 7.5.1.13. Rest of Latin America Host Cell Contaminant Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 7.5.1.14. Rest of Latin America Host Cell Contaminant Testing Market by Platform, Value (US$ Bn), 2018 - 2031
      • 7.5.1.15. Rest of Latin America Host Cell Contaminant Testing Market by Application, Value (US$ Bn), 2018 - 2031
      • 7.5.1.16. Rest of Latin America Host Cell Contaminant Testing Market by End User, Value (US$ Bn), 2018 - 2031
    • 7.5.2. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Host Cell Contaminant Testing Market Outlook, 2018 - 2031

  • 8.1. Middle East & Africa Host Cell Contaminant Testing Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
    • 8.1.1. Key Highlights
      • 8.1.1.1. PCR-based Assays
      • 8.1.1.2. ELISA-based Assays
  • 8.2. Middle East & Africa Host Cell Contaminant Testing Market Outlook, by Platform, Value (US$ Bn), 2018 - 2031
    • 8.2.1. Key Highlights
      • 8.2.1.1. Microbial
      • 8.2.1.2. Mammalian
      • 8.2.1.3. Others
  • 8.3. Middle East & Africa Host Cell Contaminant Testing Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
    • 8.3.1. Key Highlights
      • 8.3.1.1. Research & Development
      • 8.3.1.2. Clinical Applications
  • 8.4. Middle East & Africa Host Cell Contaminant Testing Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
    • 8.4.1. Key Highlights
      • 8.4.1.1. Biopharmaceutical Companies
      • 8.4.1.2. Contract Research Organizations
      • 8.4.1.3. Contract Manufacturing Organizations
      • 8.4.1.4. Academic & Research Institutes
  • 8.5. Middle East & Africa Host Cell Contaminant Testing Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 8.5.1. Key Highlights
      • 8.5.1.1. GCC Host Cell Contaminant Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 8.5.1.2. GCC Host Cell Contaminant Testing Market by Platform, Value (US$ Bn), 2018 - 2031
      • 8.5.1.3. GCC Host Cell Contaminant Testing Market by Application, Value (US$ Bn), 2018 - 2031
      • 8.5.1.4. GCC Host Cell Contaminant Testing Market by End User, Value (US$ Bn), 2018 - 2031
      • 8.5.1.5. South Africa Host Cell Contaminant Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 8.5.1.6. South Africa Host Cell Contaminant Testing Market by Platform, Value (US$ Bn), 2018 - 2031
      • 8.5.1.7. South Africa Host Cell Contaminant Testing Market by Application, Value (US$ Bn), 2018 - 2031
      • 8.5.1.8. South Africa Host Cell Contaminant Testing Market by End User, Value (US$ Bn), 2018 - 2031
      • 8.5.1.9. Egypt Host Cell Contaminant Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 8.5.1.10. Egypt Host Cell Contaminant Testing Market by Platform, Value (US$ Bn), 2018 - 2031
      • 8.5.1.11. Egypt Host Cell Contaminant Testing Market by Application, Value (US$ Bn), 2018 - 2031
      • 8.5.1.12. Egypt Host Cell Contaminant Testing Market by End User, Value (US$ Bn), 2018 - 2031
      • 8.5.1.13. Nigeria Host Cell Contaminant Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 8.5.1.14. Nigeria Host Cell Contaminant Testing Market by Platform, Value (US$ Bn), 2018 - 2031
      • 8.5.1.15. Nigeria Host Cell Contaminant Testing Market by Application, Value (US$ Bn), 2018 - 2031
      • 8.5.1.16. Nigeria Host Cell Contaminant Testing Market by End User, Value (US$ Bn), 2018 - 2031
      • 8.5.1.17. Rest of Middle East & Africa Host Cell Contaminant Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 8.5.1.18. Rest of Middle East & Africa Host Cell Contaminant Testing Market by Platform, Value (US$ Bn), 2018 - 2031
      • 8.5.1.19. Rest of Middle East & Africa Host Cell Contaminant Testing Market by Application, Value (US$ Bn), 2018 - 2031
      • 8.5.1.20. Rest of Middle East & Africa Host Cell Contaminant Testing Market by End User, Value (US$ Bn), 2018 - 2031
    • 8.5.2. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

  • 9.1. Product Type vs Platform Heatmap
  • 9.2. Manufacturer vs Platform Heatmap
  • 9.3. Company Market Share Analysis, 2023
  • 9.4. Competitive Dashboard
  • 9.5. Company Profiles
    • 9.5.1. BioGenes GmbH
      • 9.5.1.1. Company Overview
      • 9.5.1.2. Product Type Portfolio
      • 9.5.1.3. Financial Overview
      • 9.5.1.4. Business Strategies and Development
    • 9.5.2. Bio-Rad Laboratories, Inc.
      • 9.5.2.1. Company Overview
      • 9.5.2.2. Product Type Portfolio
      • 9.5.2.3. Financial Overview
      • 9.5.2.4. Business Strategies and Development
    • 9.5.3. Cisbio Bioassays
      • 9.5.3.1. Company Overview
      • 9.5.3.2. Product Type Portfolio
      • 9.5.3.3. Financial Overview
      • 9.5.3.4. Business Strategies and Development
    • 9.5.4. Cygnus Technologies LLC
      • 9.5.4.1. Company Overview
      • 9.5.4.2. Product Type Portfolio
      • 9.5.4.3. Financial Overview
      • 9.5.4.4. Business Strategies and Development
    • 9.5.5. Enzo Life Sciences, Inc.
      • 9.5.5.1. Company Overview
      • 9.5.5.2. Product Type Portfolio
      • 9.5.5.3. Financial Overview
      • 9.5.5.4. Business Strategies and Development
    • 9.5.6. ForteBio
      • 9.5.6.1. Company Overview
      • 9.5.6.2. Product Type Portfolio
      • 9.5.6.3. Financial Overview
      • 9.5.6.4. Business Strategies and Development
    • 9.5.7. GE Healthcare Life Sciences
      • 9.5.7.1. Company Overview
      • 9.5.7.2. Product Type Portfolio
      • 9.5.7.3. Financial Overview
      • 9.5.7.4. Business Strategies and Development
    • 9.5.8. Molecular Devices LLC
      • 9.5.8.1. Company Overview
      • 9.5.8.2. Product Type Portfolio
      • 9.5.8.3. Financial Overview
      • 9.5.8.4. Business Strategies and Development
    • 9.5.9. ProteinSimple
      • 9.5.9.1. Company Overview
      • 9.5.9.2. Product Type Portfolio
      • 9.5.9.3. Financial Overview
      • 9.5.9.4. Business Strategies and Development
    • 9.5.10. Thermo Fisher Scientific, Inc.
      • 9.5.10.1. Company Overview
      • 9.5.10.2. Product Type Portfolio
      • 9.5.10.3. Financial Overview
      • 9.5.10.4. Business Strategies and Development

10. Appendix

  • 10.1. Research Methodology
  • 10.2. Report Assumptions
  • 10.3. Acronyms and Abbreviations